U. S. Securities and Exchange Commission
                         Washington, D. C.  20549

                                FORM 10-QSB


[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the quarterly period ended March 31, 2005

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the transition period from                to
                                    --------------    ---------------

                     Commission File No.  000-31377

                          REFLECT SCIENTIFIC, INC.
                          ------------------------
              (Name of Small Business Issuer in its Charter)

             UTAH                                      87-0642556
             ----                                      ----------
  (State or Other Jurisdiction of              (I.R.S. Employer I.D. No.)
 incorporation or organization)

                          970 Terra Bella Avenue
                     Mountain View, California, 94043
                     --------------------------------
                  (Address of Principal Executive Offices)

                 Issuer's Telephone Number:  (650) 960-0300
                                             --------------

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.

(1)  Yes  X     No                 (2)  Yes  X    No
         ---     ---                        ---     ---

<PAGE>
             APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                PROCEEDINGS DURING THE PRECEDING FIVE YEARS

                              Not applicable.


                   APPLICABLE ONLY TO CORPORATE ISSUERS

Indicate the number of shares outstanding of each of the Registrant's classes
of common stock, as of the latest practicable date:

                               April 30, 2005

                                 24,000,000
                                ----------

                      PART I - FINANCIAL INFORMATION

Item 1.   Financial Statements.
-------------------------------

          The Financial Statements of the Company required to be filed with
this 10-QSB Quarterly Report were prepared by management, and commence on the
following page, together with Related Notes.  In the opinion of management,
the Financial Statements fairly present the financial condition of the
Company.
<PAGE>
                    REFLECT SCIENTIFIC, INC.

                CONSOLIDATED FINANCIAL STATEMENTS

               March 31, 2004 and December 31, 2003
<PAGE>
                    REFLECT SCIENTIFIC, INC.
                   Consolidated Balance Sheets

                              ASSETS

                                               March 31,        December 31,
                                                2005                2004
                                             (Unaudited)
CURRENT ASSETS

     Cash                                     $   496,674      $    80,739
     Accounts receivable, net                     281,353          281,173
     Inventory, net                               269,119          260,012
     Prepaid expenses                                 800              800
                                              -----------      -----------
          Total Current Assets                  1,047,946          622,724
                                              -----------      -----------
FIXED ASSETS (NET)                                 23,423           24,249
                                              -----------      -----------
OTHER ASSETS

     Deposits                                       5,350            5,350
     Capitalized loan costs, net                    5,250            5,600
                                              -----------      -----------
          Total Other Assets                       10,600           10,950
                                              -----------      -----------
          TOTAL ASSETS                        $ 1,081,969      $   657,923
                                              ===========      ===========

The accompanying notes are an integral part of these consolidated financial
statements.
                                2
<PAGE>
                    REFLECT SCIENTIFIC, INC.
             Consolidated Balance Sheets (Continued)


               LIABILITIES AND SHAREHOLDERS' EQUITY

                                               March 31,        December 31,
                                                2005                2004
                                             (Unaudited)
CURRENT LIABILITIES

     Accounts payable                         $    149,745     $    131,610
     Accrued expenses                                3,456           23,955
     Income taxes payable                           30,705           30,705
                                              ------------     ------------
          Total Current Liabilities                183,906          186,270
                                              ------------     ------------
NON-CURRENT LIABILITIES

     Long term line of credit                      269,011          269,036
     Deferred income taxes                          39,000           39,000
                                              ------------     ------------
          Total Non-Current Liabilities            308,011          308,036
                                              ------------     ------------
          Total Liabilities                        491,917          494,306
                                              ------------     ------------
COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' EQUITY

     Preferred stock, $0.01 par value,
     authorized 5,000,000 shares, 436,000
     shares issued and outstanding                   4,360                -
     Common stock, $0.01 par value, authorized
     50,000,000 shares; 24,000,000 shares
     issued and outstanding                        240,000          240,000
     Additional paid-in capital (deficit)          248,321         (183,319)
     Retained earnings                              97,372          106,936
                                             -------------     ------------
          Total Shareholders' Equity               590,052          163,617
                                             -------------     ------------
          TOTAL LIABILITIES AND SHAREHOLDERS'
          EQUITY                             $   1,081,969     $    657,923
                                             =============     ============

The accompanying notes are an integral part of these consolidated financial
statements.
                                3
<PAGE>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Operations
                           (Unaudited)


                                        For the Three Months Ended
                                                March 31,
                                          2005                2004
REVENUES                                $    507,392     $  500,051

COST OF GOODS SOLD                           311,107        311,123
                                        ------------     ----------
GROSS PROFIT                                 196,285        188,928
                                        ------------     ----------
OPERATING EXPENSES

     Salaries and wages                       70,108         89,334
     Payroll taxes                             7,498          8,792
     Rent expense                             18,859         19,059
     General and
      administrative expense                 109,384         70,530
                                        ------------     ----------
          Total Operating Expenses           201,735        187,715
                                        ------------     ----------
OPERATING INCOME (LOSS)                       (5,450)         1,213
                                        ------------     ----------
OTHER INCOME (EXPENSE)

     Miscellaneous expenses                        -           (301)
     Interest expense                         (4,114)        (2,856)
                                        ------------     ----------
          Total Other Expenses                (4,114)        (3,157)
                                        ------------     ----------
NET LOSS                                $     (9,564)    $   (1,944)
                                        ------------     ----------
Preferred distribution, dividends           (147,313)             -

NET LOSS PER SHARE APPLICABLE TO COMMON
SHAREHOLDERS                            $   (156,877)    $   (1,944)
                                        ============     ==========
EARNINGS PER SHARE                      $      (0.01)    $    (0.00)
                                        ============     ==========
WEIGHTED AVERAGE NUMBER OF SHARES
  OUTSTANDING                             24,000,000     24,000,000
                                        ============     ==========

The accompanying notes are an integral part of these consolidated financial
statements.
                                4
<PAGE>
                    REFLECT SCIENTIFIC, INC.
         Consolidated Statements of Shareholders' Equity


                                                        Additional
                      Common Stock     Preferred Stock   Paid-in    Retained
                    Shares      Amount  Shares  Amount   Capital    Earnings
Net income for
the year ended
December  31, 2002          -         -       -       -          -    141,018
                   ----------  -------- -------  ------    ------- ----------
Balance, December
31, 2002           22,914,949    10,000       -       -          -    161,637

Dividend                    -         -       -       -          -   (156,000)

Contributed Capital         -         -       -       -     26,950          -

Recapitalization
(Note 2)            1,085,051   230,000       -       -   (237,791)         -

Net income for the
year ended
December 31, 2003           -         -       -       -          -     58,672
                   ----------  -------- -------  ------  --------- ----------
Balance, December
31, 2003           24,000,000   240,000       -       -   (210,841)    64,309

Contributed capital
(unaudited)                 -         -       -       -     27,522          -

Net income for the
year ended December
31, 2004                    -         -       -       -          -     42,627
                   ----------  -------- -------  ------  ---------  ---------
Balance,
December 31, 2004  24,000,000  $240,000       -  $    -  $(183,319) $ 106,936

Preferred stock
issued for cash             -         - 436,000   4,360    431,640          -

Net income for the
three months ended
March 31, 2005
(unaudited)                 -         -       -       -          -     (9,564)
                   ----------  -------- -------  ------  --------- ----------
Balances,
March 31, 2005
(unaudited)        24,000,000  $240,000 436,000  $4,360  $ 248,321 $   97,372
                   ==========  ======== =======  ======  ========= ==========

The accompanying notes are an integral part of these consolidated financial
statements.
                                5
<PAGE>
                    REFLECT SCIENTIFIC, INC.
              Consolidated Statements of Cash Flows
                           (Unaudited)

                                        For the Three Months Ended
                                                March 31,
                                          2005                2004
CASH FLOWS FROM OPERATING ACTIVITIES

     Net income (loss)                    $    (9,564)    $    (1,944)
     Adjustments to reconcile net income
      to net cash provided by operating
      activities:
          Depreciation                            826             492
          Amortization of capitalized loan
          costs                                   350             175
     Changes in operating assets and
     liabilities:
          Increase in accounts receivable        (181)        (50,554)
          Increase decrease in inventory       (9,107)        (28,928)
          Decrease in accounts payable and
          accrued expenses                     (2,364)        (23,862)
                                           ----------     -----------
               Net Cash Used by Operating
               Activities                     (20,040)       (104,621)

CASH FLOWS FROM INVESTING ACTIVITIES

     Purchases of fixed assets                      -               -
                                           ----------     -----------
               Net Cash Used by Investing
               Activities                           -               -
                                           ----------     -----------
CASH FLOWS FROM FINANCING ACTIVITIES

     Payments on short term lines of credit         -               -
     Change in long term line of credit           (25)            (25)
     Contributed capital                            -          22,522
     Proceeds from stock issuance             436,000               -
                                           ----------     -----------
               Net Cash Provided (Used) by
               Financing Activities           435,975          22,497
                                           ----------     -----------
NET INCREASE (DECREASE) IN CASH               415,935         (82,124)

CASH AT BEGINNING OF PERIOD                    80,739          99,924
                                           ----------     -----------
CASH AT END OF PERIOD                      $  496,674     $    17,800
                                           ==========     ===========

NON-CASH INVESTING AND FINANCING ACTIVITIES:

     Cash Paid For:

          Interest                         $    4,119     $     1,879
          Income taxes                     $        -     $         -


The accompanying notes are an integral part of these consolidated financial
statements.
                                6
<PAGE>
                    REFLECT SCIENTIFIC, INC.
          Notes to the Consolidated Financial Statements
               March 31, 2005 and December 31, 2004


NOTE 1 -  BASIS OF FINANCIAL STATEMENT PRESENTATION

     The accompanying unaudited condensed consolidated financial statements
     have been prepared by the Company pursuant to accounting principles
     generally accepted in the United States of America. Certain information
     and footnote disclosures normally included in financial statements
     prepared in accordance with accounting principles generally accepted in
     the United States of America have been condensed or omitted in
     accordance with such rules and regulations.  The information furnished
     in the interim condensed consolidated financial statements include
     normal recurring adjustments and reflects all adjustments, which, in the
     opinion of management, are necessary for a fair presentation of such
     financial statements.  Although management believes the disclosures and
     information presented are adequate to make the information not
     misleading, it is suggested that these interim condensed consolidated
     financial statements be read in conjunction with the Company's most
     recent audited consolidated financial statements and notes thereto
     included in its December 31, 2004 financial statements.  Operating
     results for the three months ended March 31, 2004 are not necessarily
     indicative of the results that may be expected for the year ending
     December 31, 2005.

NOTE 2 -  ACQUISITION OF REFLECT SCIENTIFIC

     On December 30, 2003, pursuant to an agreement and plan of
     reorganization, the Company completed a reverse merger with the
     shareholder of Reflect Scientific, Inc. in which it acquired 100% of
     Reflect Scientific, Inc., a California Company in exchange for
     22,914,949 common shares of the Company.  The terms of the acquisition
     are detailed in an 8-K filing dated December 31, 2003.  Under the terms
     of the agreement, the President of Reflect Scientific, Inc. became the
     President of the Company and was elected to the Board of Directors, the
     acquisition was accounted for as a recapitalization of Reflect
     Scientific, Inc. because the members of Reflect Scientific, Inc.
     controlled the Company after the acquisition.  Reflect Scientific, Inc.
     was treated as the acquiring entity for accounting purposes and Cole,
     Inc. was the surviving entity for legal purposes.  There was no
     adjustment to the carrying values of the assets or liabilities of
     Reflect Scientific, Inc. and no goodwill was recorded.


NOTE 3   EQUITY TRANSACTIONS

     Dividends

     The holders of the Series A Preferred Stock are entitled to dividends at
     the rate of  8 percent per year of the liquidation preference of $1.00
     per share, payable annually, if and when declared by the board of
     directors. Dividends are not cumulative and the board of directors are
     under no obligation to declare dividends.

                                7
<PAGE>
                    REFLECT SCIENTIFIC, INC.
          Notes to the Consolidated Financial Statements
              March 31, 2005 and December 31, 2004

NOTE 3   EQUITY TRANSACTIONS (continued)

     Convertibility

     Upon the approval of the Board of Directors, Series A Preferred Stock
     may be convertible into the Company's common stock by dividing $1.00
     plus any unpaid dividends by 50% of the five day average closing bid
     price of the common shares.

     During the year the Company sold 436,000 shares of Series A Convertible
     Preferred Stock in exchange for proceeds of $436,000. As a result of the
     beneficial conversion feature inherent in the conversion rights and
     preferences of Series A Preferred Stock, the Company has recognized a
     deemed dividend of $436,000. This deemed dividend was calculated based
     on the conversion price above at the time of conversion. Because the
     Company does not have sufficient retained earnings, dividends were
     recorded in additional paid-in-capital and have a net affect of zero in
     that account and is therefore not presented on the statement of
     shareholders' equity as a separate item.  This beneficial conversion
     feature was recorded to additional paid in capital and will be recorded
     as a deemed dividend to preferred shareholders (accretion) over the
     period to the instruments earliest conversion date. The Company projects
     that the preferred shareholders should be able to convert by June 30,
     2005.

NOTE 4 -  SUBSEQUENT EVENT

     In May of 2005 the Board of Directors authorized the issuance of 380,000
     shares of the Company's common stock to certain officers, directors and
     staff of the Company for services rendered.

                                8
<PAGE>

Item 2.   Management's Discussion and Analysis or Plan of Operation.
--------------------------------------------------------------------

Results of Operations.
----------------------

          Our revenues increased during the quarter ended March 31, 2005, to
$507,392, from $500,051 for the quarter ended March 31, 2004, primarily as
a result of a general improvement in sales across several product lines and
improving market conditions.

          Our cost of goods decreased slightly in the period ending March 31,
2005, as compared to March 31, 2004, to $311,107 from $311,123.

          General and administrative expenses increased to $109,384 during the
quarter ended March 31, 2005, from $70,530 during the quarter ended March 31,
2004. This increase was due to the addition of one full-time employee,
increased payroll and increased operational expenses, like legal and
accounting fees.

     Liquidity and Capital Resources.
     --------------------------------

          Our cash resources at March 31, 2005, were $496,674, with accounts
receivable of $281,353.  We have relied on revenues and lines of credit for
our cash resources.  At March 31, 2005, we had utilized $269,011 of our
$400,000 line of credit.  These funds should be adequate for the next 12
months for continuing operations; however, plans for expansion will require
additional capital of between $500,000 and $750,000.

     Forward-Looking Statements.
     ---------------------------

         The Private Securities Litigation Reform Act of 1995 (the "Act")
provides a safe harbor for forward-looking statements made by or on behalf of
our Company.  Our Company and its representatives may from time to time make
written or oral statements that are "forward- looking," including statements
contained in this Quarterly Report and other filings with the Securities and
Exchange Commission and in reports to our Company's stockholders. Management
believes that all statements that express expectations and projections with
respect to future matters, as well as from developments beyond our Company's
control including changes in global economic conditions are forward-looking
statements within the meaning of the Act. These statements are made on the
basis of management's views and assumptions, as of the time the statements are
made, regarding future events and business performance. There can be no
assurance, however, that management's expectations will necessarily come to
pass.  Factors that may affect forward- looking statements include a wide
range of factors that could materially affect future developments and
performance, including the following:

         Changes in Company-wide strategies, which may result in changes in
the types or mix of businesses in which our Company is involved or chooses to
invest; changes in U.S., global or regional economic conditions, changes in
U.S. and global financial and equity markets, including significant interest
rate fluctuations, which may impede our Company's access to, or increase the
cost of, external financing for our operations and investments; increased
competitive pressures, both domestically and internationally, legal and
regulatory developments, such as regulatory actions affecting environmental
activities, the imposition by foreign countries of trade restrictions and
changes in international tax laws or currency controls; adverse weather
conditions or natural disasters, such as hurricanes and earthquakes, labor
disputes, which may lead to increased costs or disruption of operations.

         This list of factors that may affect future performance and the
accuracy of forward-looking statements is illustrative, but by no means
exhaustive.  Accordingly, all forward-looking statements should be evaluated
with the understanding of their inherent uncertainty.

Item 3. Controls and Procedures.
----------------------------------

          As of the end of the period covered by this Quarterly Report, we
carried out an evaluation, under the supervision and with the participation of
our President and Treasurer, of the effectiveness of our disclosure controls
and procedures.  Based on this evaluation, our President and Treasurer
concluded that our disclosure controls and procedures are effective in timely
alerting them to material information required to be included in our periodic
Securities and Exchange Commission reports.  It should be noted that the
design of any system of controls is based in part upon certain assumptions
about the likelihood of future events, and there can be no assurance that any
design will succeed in achieving its stated goals under all potential future
conditions, regardless of how remote.  In addition, we reviewed our internal
controls over financial reporting, and there have been no changes in our
internal controls or in other factors in the last fiscal quarter that has
materially affected or is reasonably likely to materially affect our internal
control over financial reporting.

                        PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.
----------------------------

          None; not applicable.

Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds.
----------------------------------------------------------------------

          2004 Convertible Preferred Stock.
          ---------------------------------

          During the quarter ended March 31, 2005, we sold 436,000 shares of
our 2004 Series A Convertible Preferred Stock at an offering price of $1.00
per share to 22 persons who were "accredited investors" as that term in
defined in Regulation D of the Securities and Exchange Commission.

          We issued all of these securities to persons who were either
"accredited investors," or "sophisticated investors" who, by reason of
education, business acumen, experience or other factors, were fully capable of
evaluating the risks and merits of an investment in our company; and each had
prior access to all material information about us.  We believe that the offer
and sale of these securities were exempt from the registration requirements of
the Securities Act, pursuant to Sections 4(2) and 4(6) thereof, and Rule 506
of Regulation D of the Securities and Exchange Commission and from various
similar state exemptions.  See Note 3 of our consolidated financial statements
that accompany this Quarterly Report, in Part I, Item 1, above.

Item 3.   Defaults Upon Senior Securities.
------------------------------------------

          None; not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.
--------------------------------------------------------------

          None; not applicable.

Item 5.   Other Information.
----------------------------

          None; not applicable.

Item 6.   Exhibits.
-------------------

          Exhibits.

               31.1   302 Certification of Kim Boyce

               31.2   302 Certification of Kevin Cooksy

               32     906 Certification.


                               SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                          REFLECT SCIENTIFIC, INC.

Date: 5/11/05                             /s/Kim Boyce
                                          ------------------------------------
                                          Kim Boyce, President


Date: 5/11/05                             /s/Tom Tait
                                          ------------------------------------
                                          Tom Tait, Vice President


Date: 5/11/05                             /s/Kevin Cooksy
                                          ------------------------------------
                                          Kevin Cooksy, Secretary/Treasurer
<PAGE>